Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-01-22

Clinical Trial Update: Additive Effect of Endonase on Eradication Rate of First Line Therapy for Helicobacter Pylori [NA]

View source ↗

Summary

A completed clinical trial evaluated whether adding Endonase to first-line therapy improves Helicobacter pylori eradication rates in patients with gastric ulcer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Endonase

Snippet

Sponsor: Chuncheon Sacred Heart Hospital | Conditions: Gastric Ulcer Associated With Helicobacter Pylori | NA | Status: COMPLETED